Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | ANPEP | P15144 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.34 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.34 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17108537 | 1.00 | USP2 (0.48) | USP2ALDH1A1ANPEPLMNAPKM | |
| SCHEMBL27015205 | 0.82 | KMT2A (0.42) | ALDH1A1ANPEPLMNAMEN1KMT2A | |
| SCHEMBL19919871 | 0.81 | USP2 (0.50) | USP2ALDH1A1ANPEPLMNAMEN1 | |
| SCHEMBL16316628 | 0.81 | USP2 (0.50) | USP2ALDH1A1ANPEPLMNAMEN1 | |
| SCHEMBL26724624 | 0.80 | MEN1 (0.46) | USP2ALDH1A1ANPEPLMNAMEN1 | |
| SCHEMBL17424098 | 0.80 | MEN1 (0.46) | USP2ALDH1A1ANPEPLMNAMEN1 | |
| SCHEMBL17788475 | 0.80 | USP2 (0.45) | USP2ALDH1A1ANPEPLMNAPKM | |
| SCHEMBL24946213 | 0.79 | USP2 (0.54) | USP2ALDH1A1ANPEPLMNAMEN1 | |
| SCHEMBL8434051 | 0.78 | ALDH1A1 (0.50) | USP2ALDH1A1ANPEPLMNAMEN1 | |
| Hydrochloric Acid SCHEMBL18726103 | 0.78 | ALDH1A1 (0.50) | USP2ALDH1A1ANPEPLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873291-B2 | Quinoline cGAS antagonist compounds | IMMUNESENSOR THERAPEUTICS, INC. (US) | 2024-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11873291-B2 | Quinoline cGAS antagonist compounds | CGAS, GLS2, GLS | USP2 1956/4885ALDH1A1 4236/4885ANPEP 1189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.